Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

Poster Presentation: Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of the Novel Oral Fetal Hemoglobin (HBF) Induer Pociredir in Healthy Adults in a Phase 1 study (PF1170 – Friday, June 13) ...

The American Society for Health Care Engineering will hold its 2025 Health Care Facilities Innovation Conference July 27-30 ...

Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in patients with ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule ...

LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) unveiled significant findings from its Phase 3 IMPALA-2 clinical trial of ...

Clinical validation of the Azymetric platform is demonstrated by the accelerated approval our partner Jazz Pharmaceuticals received from the U.S. Food and Drug Administration in 2024 for Ziihera® ...

AIHA Conference and Expo brings professionals together for a dynamic week of education, innovation, and hands-on learning in ...

Their research findings and creative works are presented at international conferences, local symposia, and community events. From scholarly lectures to TED-style talks, from academic posters to ...

Presentation at the American Thoracic Society (ATS) 2025 International Conference – San Francisco ... 4:15 pm PDT Main Poster Area – Poster Board #616 About Median Technologies: Pioneering innovative ...